carbogen has been researched along with Chromosome-Defective Micronuclei in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, M; Akaboshi, M; Akuta, K; Kawai, K; Kinashi, Y; Masunaga, S; Ono, K; Suzuki, M; Takagaki, M | 1 |
1 other study(ies) available for carbogen and Chromosome-Defective Micronuclei
| Article | Year |
|---|---|
An attempt to enhance chemosensitivity of quiescent cell populations in solid tumors by combined treatment with nicotinamide and carbogen.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carbon Dioxide; Carcinoma, Squamous Cell; Cell Division; Cell Hypoxia; Cisplatin; Drug Screening Assays, Antitumor; Drug Synergism; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Micronuclei, Chromosome-Defective; Niacinamide; Oxygen; Sarcoma, Experimental | 1996 |